{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:22:01Z","timestamp":1762111321975},"reference-count":34,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MOP-119332"],"award-info":[{"award-number":["MOP-119332"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.schres.2015.12.015","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T17:36:27Z","timestamp":1452274587000},"page":"265-270","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Polygenic risk score prediction of antipsychotic dosage in schizophrenia"],"prefix":"10.1016","volume":"170","author":[{"given":"Nuwan C.","family":"Hettige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher B.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2015.12.015_bb0005","article-title":"Common polygenic variation and risk for childhood-onset schizophrenia","volume":"1\u20133","author":"Ahn","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2015.12.015_bb0010","series-title":"Meyler's Side Effects of Psychiatric Drugs","first-page":"255","article-title":"Amisulpride","author":"Aronson","year":"2008"},{"issue":"2","key":"10.1016\/j.schres.2015.12.015_bb0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0924-9338(00)00203-0","article-title":"Addiction and schizophrenia","volume":"15","author":"Batel","year":"2000","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2015.12.015_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.2005.00540.x","article-title":"The role of dopamine in reward and pleasure behaviour \u2014 review of data from preclinical research","volume":"427","author":"Bressan","year":"2005","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2015.12.015_bb0025","series-title":"The Canadian Drug Reference for Health Professionals (CPS)","author":"Compendium of Pharmaceuticals and Specialties","year":"2012"},{"key":"10.1016\/j.schres.2015.12.015_bb0035","series-title":"Psychiatric Consultation in Long-Term Care: A Guide for Health Care Professionals","author":"Desai","year":"2010"},{"issue":"8","key":"10.1016\/j.schres.2015.12.015_bb0040","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/0269881115584470","article-title":"Polygenic risk scores in imaging genetics: usefulness and applications","volume":"29","author":"Dima","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.schres.2015.12.015_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003348","article-title":"Power and predictive accuracy of polygenic risk scores","volume":"9","author":"Dudbridge","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.schres.2015.12.015_bb0050","first-page":"1149","article-title":"Statistical power analyses using G*power 3.1: tests for correlation and regression analyses. Behav. Res","volume":"41","author":"Faul","year":"2009","journal-title":"Methods"},{"key":"10.1016\/j.schres.2015.12.015_bb0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.schres.2015.12.015_bb0060","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1017\/S0033291714000610","article-title":"Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow up study","volume":"44","author":"Harrow","year":"2014","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2015.12.015_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0924-9338(02)00628-4","article-title":"Dopaminergic dysfunction in alcoholism and schizophrenia \u2014 psychopathological and behavioral correlates","volume":"17","author":"Heinz","year":"2002","journal-title":"Eur. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.12.015_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes","volume":"68","author":"Ho","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.schres.2015.12.015_bb0075","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.2354","article-title":"Fast and accurate genotype imputation in genome-wide association studies through pre-phasing","volume":"44","author":"Howie","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.schres.2015.12.015_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/1471-2164-11-724","article-title":"Accounting for multiple comparisons in a genome-wide association study (GWAS)","volume":"11","author":"Johnson","year":"2010","journal-title":"BMC Genomics"},{"issue":"7","key":"10.1016\/j.schres.2015.12.015_bb0090","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/gim.2014.143","article-title":"Summarizing polygenic risks for complex diseases in a clinical whole-genome report","volume":"17","author":"Kong","year":"2015","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.schres.2015.12.015_bb0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.schres.2015.12.015_bb0100","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1345\/aph.1A440","article-title":"Metoclopramide-induced supersensitivity psychosis","volume":"36","author":"Lu","year":"2002","journal-title":"Ann. Pharmacother."},{"issue":"8","key":"10.1016\/j.schres.2015.12.015_bb0105","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1017\/S0033291714002839","article-title":"Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis","volume":"45","author":"Musliner","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2015.12.015_bb0110","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2013.203","article-title":"Cortical folding defects as markers of poor treatment response in first-episode schizophrenia","volume":"70","author":"Palaniyappan","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2015.12.015_bb0115","first-page":"100","article-title":"A dimensional and categorical architecture for the classification of psychotic disorders","volume":"6","author":"Peralta","year":"2007","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2015.12.015_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/mp.2014.105","article-title":"Genetics and intelligence differences: five special findings","volume":"20","author":"Plomin","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.12.015_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a toolset for whole-genome association and population-based linkage analysis","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"7256","key":"10.1016\/j.schres.2015.12.015_bb0130","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.schres.2015.12.015_bb0135","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2015.12.015_bb0145","article-title":"Baseline striatal functional connectivity as a predictor of response to antipsychotic drug treatment","author":"Sarpal","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.12.015_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/jamapsychiatry.2014.1734","article-title":"Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia","volume":"72","author":"Sarpal","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7510","key":"10.1016\/j.schres.2015.12.015_bb0155","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.schres.2015.12.015_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/schbul\/sbq126","article-title":"Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia","volume":"38","author":"Szeszko","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2015.12.015_bb0165","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/acps.12307","article-title":"Polygenic risk score and the psychosis continuum model","volume":"130","author":"Tesli","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2015.12.015_bb0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature06258","article-title":"A second generation human haplotype map of over 3.1 million SNPs","volume":"449","author":"The International HapMap Consortium","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.schres.2015.12.015_bb0175","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1176\/appi.ajp.157.7.1041","article-title":"Toward reformulating the diagnosis of schizophrenia","volume":"157","author":"Tsuang","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2015.12.015_bb0180","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0920-9964(01)00352-8","article-title":"Psychotic symptoms in non-clinical populations and the continuum of psychosis","volume":"54","author":"Verdoux","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2015.12.015_bb0190","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","article-title":"D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis","volume":"167","author":"Zhang","year":"2010","journal-title":"Am. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415300876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T05:25:28Z","timestamp":1567488328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415300876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":34,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0920996415300876"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.12.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polygenic risk score prediction of antipsychotic dosage in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}